A new combination immunotherapy approach with anti-PD-L1 and HER2/neu loaded dendritic cell vaccine along with saponin adjuvant

被引：0
|
作者：
Ozverel, C. S. [1 ]
Karaboz, I. [1 ]
Nalbantsoy, A. [2 ]
机构：
[1] Ege Univ, Dept Biol, Fac Sci, Izmir, Turkey
[2] Ege Univ, Bioengn Dept, Fac Engn, Izmir, Turkey
来源：
EUROPEAN JOURNAL OF CANCER | 2018年 / 92卷
关键词：
D O I：
10.1016/j.ejca.2018.01.018
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P01.05
引用
收藏
页码：S6 / S7
页数：5
相关论文
共 31 条
  • [1] Investigation of the combination of anti-PD-L1 mAb with HER2/neu-loaded dendritic cells and QS-21 saponin adjuvant: effect against HER2 positive breast cancer in mice
    Ozverel, Cenk Serhan
    Uyanikgil, Yigit
    Karaboz, Ismail
    Nalbantsoy, Ayse
    IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 2020, 42 (04) : 346 - 357
  • [2] Adjuvant effect of anti-PD-L1 in boosting HER2-targeted T cell adoptive immunotherapy
    Xia, Yang
    Hu, Yangyang
    Wang, Yi
    Bao, Yangyi
    Dai, Fu
    Huang, Shiang
    Hurt, Elaine
    Hollingsworth, Robert E.
    Thakur, Archana
    Lum, Lawrence
    Chang, Alfred E.
    Wicha, Max S.
    Li, Qiao
    CANCER RESEARCH, 2016, 76
  • [3] Noninflammatory adjuvant improving dendritic cell priming and anti-PD-L1 efficacy
    Seya, Tsukasa
    Takeda, Yohei
    Matsumoto, Misako
    CANCER SCIENCE, 2018, 109 : 551 - 551
  • [4] A new paradigm of cancer immunotherapy based on [18F]FDG and anti-PD-L1 mAb combination
    Wen, Xuejun
    Chen, Xiaoyuan
    Zhang, Xianzhong
    Guo, Zhide
    NUCLEAR MEDICINE AND BIOLOGY, 2022, 108 : S219 - S220
  • [5] Pharmacodynamic response to HER2/CD3 bispecific antibody (HER2-TDB): evidence of T-cell recruitment and further rationale for combination treatment with anti-PD-L1
    Li, Ji
    Hristopoulos, Maria
    Clark, Robyn
    Johnston, Jennifer
    Slaga, Dion
    Wang, Bu-Er
    Cubas, Rafael
    Totpal, Klara
    Junttila, Melissa R.
    Junttila, Teemu T.
    CANCER RESEARCH, 2016, 76
  • [6] Which is the optimal immunotherapy for advanced squamous non-small-cell lung cancer in combination with chemotherapy: anti-PD-1 or anti-PD-L1?
    Zhang, Yaxiong
    Zhou, Huaqiang
    Zhang, Li
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2018, 6
  • [7] A photodynamically sensitized dendritic cell vaccine that promotes the anti-tumor effects of anti-PD-L1 monoclonal antibody in a murine model of head and neck squamous cell carcinoma
    Li, Shuang
    Wang, Ding
    Cheng, Jinzhang
    Sun, Jicheng
    Kalvakolanu, Dhan, V
    Zhao, Xue
    Wang, Di
    You, Yunhan
    Zhang, Ling
    Yu, Dan
    JOURNAL OF TRANSLATIONAL MEDICINE, 2022, 20 (01)
  • [8] A photodynamically sensitized dendritic cell vaccine that promotes the anti-tumor effects of anti-PD-L1 monoclonal antibody in a murine model of head and neck squamous cell carcinoma
    Shuang Li
    Ding Wang
    Jinzhang Cheng
    Jicheng Sun
    Dhan V. Kalvakolanu
    Xue Zhao
    Di Wang
    Yunhan You
    Ling Zhang
    Dan Yu
    Journal of Translational Medicine, 20
  • [9] A Paradigm of Cancer Immunotherapy Based on 2-[18F]FDG and Anti-PD-L1 mAb Combination to Enhance the Antitumor Effect
    Wen, Xuejun
    Shi, Changrong
    Zeng, Xinying
    Zhao, Liang
    Yao, Lanlin
    Liu, Zhida
    Feng, Lixia
    Zhang, Deliang
    Huang, Jinxiong
    Li, Yesen
    Lin, Qin
    Chen, Haojun
    Zhuang, Rongqiang
    Chen, Xiaoyuan
    Zhang, Xianzhong
    Guo, Zhide
    CLINICAL CANCER RESEARCH, 2022, 28 (13) : 2923 - 2937
  • [10] Synergistic combination of targeted nano-nuclear-reactors and anti-PD-L1 nanobodies evokes persistent T cell immune activation for cancer immunotherapy
    Zhu, Lipeng
    Li, Junnan
    Guo, Ziang
    Kwok, Hang Fai
    Zhao, Qi
    JOURNAL OF NANOBIOTECHNOLOGY, 2022, 20 (01)
1234